SCHEMBL30908464

SCHEMBL30908464

C=C(c1ccc(C(=O)OC)cn1)C(F)(F)F

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.66
KDM4E B2RXH2 2/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
NOTUM Q6P988 1/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 3/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
CA12 O43570 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
MAPT P10636 2/20 0.39
MEN1 O00255 2/20 0.39
AHR P35869 1/20 0.39
P4HTM Q9NXG6 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31282507 0.98 MAPK1 (0.64) MAPK1KDM4EL3MBTL1NOTUMLMNA
SCHEMBL29268187 0.81 MAPK1 (0.74) MAPK1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL10284462 0.81 MAPK1 (0.75) MAPK1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL69747 0.80 MAPK1 (1.00) MAPK1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL29508473 0.80 MAPK1 (1.00) MAPK1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL3966685 0.79 CA1 (0.53) MAPK1L3MBTL1NOTUMALDH1A1KMT2A
SCHEMBL64700 0.77 MAPK1 (1.00) MAPK1KDM4EL3MBTL1P4HTMP4HA1
SCHEMBL423045 0.77 MAPK1 (0.79) MAPK1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL18940452 0.77 MAPK1 (0.68) MAPK1KDM4EL3MBTL1ALDH1A1KMT2A
SCHEMBL29153940 0.76 MAPK1 (0.66) MAPK1KDM4EL3MBTL1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720060-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2026-04-08 EP disclosed
WO-2024240894-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2024-11-28 WO disclosed
WO-2024074611-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2024-04-11 WO disclosed